Dan Atar

1. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
   2007/05/04 by Authors Task Force Members, Ian D. Graham, Dan Atar +65 · 6 citations
   Medicine · Economics, Econometrics and Finance · #Clinical practice guidelines implementation #Health Systems, Economic Evaluations, Quality of Life #Cardiac, Anesthesia and Surgical Outcomes
2. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
   2023/02/13 by Prakriti Gaba, Michelle L. O’Donoghue, Jeong-Gun Park +29 · 28 citations
   Medicine · Immunology and Microbiology · #Lipoproteins and Cardiovascular Health #Diabetes, Cardiovascular Risks, and Lipoproteins #Atherosclerosis and Cardiovascular Diseases
3. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
   2013/02/20 by Stefan Agewall, Marco Cattaneo, J.‐P. Collet +14 · 1 citation
   Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Gastroesophageal reflux and treatments #Atrial Fibrillation Management and Outcomes